FDA: Cosmetic Warning Letters Carry Same Weight Regardless Of Issuing Office

摘要

Around 96% of warning letters for excessive cosmetics claims in 2016 have issued from FDA district offices as opposed to CFSAN headquarters, representing a marked shift from previous years. The agency stresses, however, that the source of a warning letter has no bearing on its implications.